Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-013323
Filing Date
2017-05-16
Accepted
2017-05-16 13:49:21
Documents
1
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3334
  Complete submission text file 0000899243-17-013323.txt   4685
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Issuer) CIK: 0001552451 (see all company filings)

EIN.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Bauer Jake (Reporting) CIK: 0001654909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37609 | Film No.: 17848029